The involvement of PGC-1α relies in mitochondrial biogenesis, β-oxidation, and lipid transport [158,160] and it's reduction in liver is associated with NAFLD progression in murine model of NAFLD [161]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.